Item 7.01. Regulation FD Disclosure.

On January 5, 2023, Emergent BioSolutions Inc. (the "Company") issued a press release announcing that the Company will serve as the subcontractor to supply RSDL® (Reactive Skin Decontamination Lotion Kit) to the U.S. military pursuant to a new procurement contract award from the U.S. Department of Defense. A copy of the Company's press release is attached hereto as Exhibit 99.1.

The information contained in this Item 7.01 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.



(d) Exhibits.

Exhibit No.                                               Description
                              Press release issued by Emergent BioSolutions Inc. on January 05,
99.1                        2023.
104                         Cover Page Interactive Data File (embedded within the Inline XBRL
                            document).

© Edgar Online, source Glimpses